Increased Serum Soluble Urokinase Plasminogen Activator Receptor Predicts Short-Term Outcome in Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure
Longitudinal analysis of serum suPAR level between survivors and nonsurvivors in HB-ACLF patients during a 4-week therapy. (a) Temporal dynamics of serum suPAR level in HB-ACLF patients between the survivors and nonsurvivors group. (b) Comparison of suPAR level at individual time between the survivors and nonsurvivors group.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.